Трудности регистрации медицинских изделий в ЕАЭС
March 26, 2024Inpharmatis and “ACADEMPHARM” Discussed in Minsk Cooperation Opportunities
The Head of the Development Department of Inpharmatis Andrey Berman met in Minsk with representatives of the State Enterprise "ACADEMPHARM" to discuss the prospects for cooperation in the area of drug registration in the EAEU and the European Union.
During the meeting at the International Medical Forum "Health" in Minsk, the parties discussed the prospects for cooperation in pharmacovigilance, registration of medicines, and dietary supplements. Andrey Berman spoke about the experience of Inpharmatis and successfully implemented projects in the markets of Europe, the EAEU, the CIS in the interests of the largest pharmaceutical companies. The parties agreed to exchange detailed information to explore opportunities for cooperation.
"ACADEMPHARM" is a state-owned pharmaceutical enterprise of the Republic of Belarus, which started with the release of 6 drugs, and in 2019 already produced 40 items. As Andrey Berman noted, Inpharmatis has more than 15 years of successful experience in the EAEU, CIS, and Europe and offers a full range of services in regulatory matters, pharmacovigilance, GMP and GDP audit, PIL Readability User Testing, as well as electronic solutions for the pharmaceutical industry and regulatory authorities.
Andrey Berman, Head of the Development Department of Inpharmatis, takes part in the largest International Medical Forum in the Republic of Belarus. The event has been held annually in Minsk for over 25 years, its main goal is the development of the pharmaceutical industry of the Republic of Belarus and the strengthening of international cooperation.
Challenges of Medical Devices Registration in the EAEU
March 26, 2024Новые поправки к Федеральному закону "Об обращении лекарственных средств" в России
March 13, 2024New Amendments in Federal Law “On Circulation of Medicines” in Russia
March 13, 2024В Грузии фармацевтические компании, не предоставившие сертификат GMP, столкнулись с новыми рисками
February 28, 2024In Georgia, Pharmaceutical Companies That Have Not Provided a GMP Certificate are Facing New Risks
February 28, 2024Получение GMP сертификата ЕАЭС обязательная процедура
February 21, 2024EAEU GMP Certificate is Mandatory
February 20, 2024Полина Домбуре, директор Inpharmatis, приняла участие в TOPRA Summit 2024
February 19, 2024Dr. Polina Dombure, Inpharmatis CEO, Participated in TOPRA Summit 2024
February 19, 2024